Radiofrequency Ablation in TIR3A Nodules With Negative Genetic Evaluation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Radiofrequency Ablation in TIR3A Nodules With Negative Genetic Evaluation — Stella

Recruiting

Back to Thyroid Nodule trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Italy

Istituto Auxologico Italiano IRCCS, Milan

Key details

Sponsor

Istituto Auxologico Italiano

Enrollment target

~30 participants

Started

January 2021

Primary completion

January 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov